Spring Discovery is a computational drug discovery platform for age-related diseases founded by Ben Kamens.
Spring Discovery is a company that develops a computational drug discovery platform for age-related diseases. It was established by Ben Kamens in 2017. It has received funding from investors such as General Catalyst, First Round Capital, and Village Global. The company is headquartered in Palo Alto, California, United States. Spring Discovery also operates a laboratory for experimental purposes in San Carlos, California.